Abstract
A ubiquitously expressed member of the cytochrome P450 superfamily, CYP51, encodes lanosterol 14α-demethylase, the first step in the conversion of lanosterol into cholesterol in mammals. The biosynthetic intermediates of lanosterol 14α-demethylation are oxysterols, which inhibit HMG-CoA reductase and sterol synthesis in mammalian cells in vitro. These oxysterols (5α-lanos-8-en-3β,32-diol and 3β-hydroxy-5α-lanost-8-en-32-al) are efficiently converted into cholesterol in vitro and are generally considered to be natural cholesterol precursors. When added to hepatocytes in high concentrations, besides their conversion into cholesterol, they are also rapidly metabolized into more polar sterols and into steryl esters. The 15α- and 15β-hydroxy epimers of 5α-lanost-8-en-3β-ol are also rapidly metabolized into more polar sterols and steryl esters but are not converted efficiently into cholesterol. Polar sterol formation from all these oxysterols is dependent on an active form of cytochrome P450. Oxysterols are potent regulators of the activities of transcription factors of the sterol regulatory element-binding protein family and of liver X-receptor α. It is proposed that the rapid, cytochrome P450-dependent metabolism of naturally occurring regulatory oxysterols provides a route for their deactivation so that they become incapable of affecting gene transcription. Inhibition of cytochrome P450 by the drug ketoconazole prevents the inactivation of such oxysterols, leading to a prolonged suppression of hepatic HMG-CoA reductase in vivo and in vitro.
Similar content being viewed by others
Abbreviations
- lanosterol:
-
5α-lanosta-8,24-dien-3β-ol
- LXRα:
-
liver Xreceptor alpha
- SREBP:
-
sterol regulatory element-binding protein
References
Gibbons, G.F., Goad, L.J. and Goodwin, T.W. (1968) The Stereo-chemistry of Hydrogen Elimination from C-15 During Cholesterol Biosynthesis. J. Chem. Soc. Chem. Commun., 1458–1460.
Akhtar, M., Freeman, C.W., Wilton, D.C., Boar, R.B., and Copsey, D.B. (1977) Oxidative Metabolism of Lanosterol in the Biosynthesis of Cholesterol. Bioorg. Chem. 6, 473–481.
Gibbons, G.F., Mitropoulos, K.A., and Myant, N.B. (1982). Biochemistry of Cholesterol, pp. 131–188. Elsevier Biomedical Press, Amsterdam.
Gibbons, G.F., and Mitropoulos, K.A. (1973) The Role of Cytochrome P-450 in Cholesterol Biosynthesis. Eur. J. Biochem. 40, 267–273.
Alexander, K.T.W., Mitropoulos, K.A., and Gibbons, G.F. (1974) A Possible Role for Cytochrome P450 During the Biosynthesis of Zymosterol from Lanosterol by Saccharomyces cerevisiae, Biochem. Biophys. Res. Commun. 60, 460–467.
Stromstedt, M., Rozman, D., and Waterman, M.R. (1996) The Ubiquitously Expressed Human CYP51 Encodes Lanosterol 14 α-Demethylase, a Cytochrome P450 Whose Expression Is Regulated by Oxysterols, Arch. Biochem. Biophys. 329, 73–81.
Debeliak, N., Horvat, S., Vouk, K., Lee, M., and Rozman, D. (2000) Characterization of the Mouse Lanosterol 14α-Demethylase (CYP51), a New Member of the Evolutionarily Most Conserved Cytochrome P450 Family, Arch. Biochem. Biophys. 379, 37–45.
Nelson, D.R., Kamataki, T., Waxman, D.J., Guengerich, F.P., Estabrook, R.W., Feyereisen, R., Gonzalez, F.J., Coon, M.J., Gunsalus, I.C., Gotoh, O., et al. (1993) The P450 Superfamily: Update on New Sequences, Gene Mapping. Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature, DNA Cell Biol. 12, 1–51.
Gibbons, G.F., Mitropoulos, K.A., and Pullinger, C.R. (1976) Lanosterol 14α-Demethylase. The Metabolism of Some Potential Intermediates by Cell-free Systems from Rat Liver, Biochem. Biophys. Res. Commun. 69, 781–789.
Akhtar, M., Alexander, K., Boar, R.B., McGhie, J.F., and Barton, D.H. (1978) Chemical and Enzymic Studies on the Characterization of Intermediates During the Removal of the 14α-Methyl Group in Cholesterol Biosynthesis. The Use of 32-Functionalized Lanostane Derivatives. Biochem. J. 169, 449–463.
Trzaskos, J.M. (1995) Oxylanosterols as Modifiers of Cholesterol Biosynthesis. Prog. Lipid Res. 34, 99–116.
Kandutsch, A.A., and Chen, H.W. (1973) Inhibition of Sterol Synthesis in Cultured Mouse Cells by 7α-Hydroxycholesterol, 7β-Hydroxycholesterol and 7-Ketocholesterol, J. Biol. Chem. 248, 8408–8417.
Kandutsch, A.A., Chen, H.W., and Heiniger, H.J. (1978) Biological Activity of Some Oxygenated Sterols, Science 201, 498–501.
Schroepfer, G.J., Jr. (2000) Oxysterols: Modulators of Cholesterol Metabolism and Other Processes. Physiol. Rey. 80, 361–554.
Horton, J.D., Goldstein, J.L., and Brown, M.S. (2002) SREBPs: Activators of the Complete Program of Cholesterol and Fatty Acid Synthesis in the Liver, J. Clin. Invest. 109, 1125–1131.
Brown, M.S., and Goldstein, J.L. (1999) A Proteolytic Pathway That Controls the Cholesterol Content of Membranes, Cells, and Blood, Proc. Natl. Acad. Sci. USA 96, 11041–11048.
Janowski, B.A., Willy, P.J., Devi, T.R., Falck, J.R., and Mangelsdorf, D.J. (1996) An Oxysterol Signalling Pathway Mediated by the Nuclear Receptor LXRα, Nature 383, 728–731.
Peet, D.J., Turley, S.D., Ma, W., Janowski, B.A., Lobaccaro, J.M., Hammer, R.E., and Mangelsdorf, D.J. (1998) Cholesterol and Bile Acid Metabolism Are Impaired in Mice Lacking the Nuclear Oxysterol Receptor LXRα, Cell 93, 693–704.
Lehmann, J.M., Kliewer, S.A., Moore, L.B., Smith-Oliver, T.A., Oliver, B.B., Su, J.L., Sundseth, S.S., Winegar, D.A., Blanchard, D.E., Spencer, T.A., and Willson, T.M. (1997) Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway. J. Biol. Chem. 272, 3137–3140.
Forman, B.M., Ruan, B., Chen, J., Schroepfer, G.J., Jr., and Evans, R.M. (1997) The Orphan Nuclear Receptor LXRα is Positively and Negatively Regulated by Distinct Products of Mevalonate Metabolism, Proc. Natl. Acad. Sci. USA 94, 10588–10593.
Schultz, J.R., Tu, H., Luk, A., Repa, J.J., Medina, J.C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D.J., et al. (2000) Role of LXRs in Control of Lipogenesis, Genes Dev. 14, 2831–2838.
Repa, J.J., Turley, S.D., Lobaccaro, J.A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R.A., Dietschy, J.M., and Mangelsdorf, D.J. (2000) Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers, Science 289, 1524–1529.
Gibbons, G.F., Pullinger, C.R., Chen, H.W., Cavenee, W.K., and Kandutsch, A.A. (1980) Regulation of Cholesterol Synthesis in Cultured Cells by Probable Natural Precursor Sterols. J. Biol. Chem. 255, 375–400.
Cavenee, W.K., Gibbons, G.F., Chen, H.W., and Kandutsch, A.A. (1979) Effects of Various Oxygenated Sterols on Cellular Sterol Biosynthesis in Chinese Hamster Lung Cells Resistant to 25-Hydroxycholesterol, Biochim. Biophys. Acta 575, 255–265.
Gibbons, G.F., Pullinger, C.R., Baillie, T.A., and Clare, R.A. (1980) Metabolism of Hydroxysterols by Rat Liver, Biochim. Biophys. Acta 619, 98–106.
Gibbons, G.F. (1983) The Role of Oxysterols in the Regulation of HMG-CoA Reductase, Biochem. Soc. Trans. 11, 649–651.
Marco de la Calle, C., Hwang, W., Pullinger, C.R., and Gibbons, G.F. (1988) A Relationship Between the Activities of Hepatic Lanosterol 14α-Demethylase and 3-Hydroxy-3-menthylglutaryl CoA Reductase, Biochem. J. 250, 33–39.
Iglesias, J., and Gibbons, G.F. (1989) Regulation of Hepatic Cholesterol Biosynthesis. Effects of a Cytochrome P-450 Inhibitor on the Formation and Metabolism of Oxygenated Products of Lanosterol, Biochem. J. 264, 495–502.
Gibbons, G.F., and Ramananda, K. (1975) Synthesis and Configuration at C-15 of the Epimeric 5α-Lanost-8-en-3β,15-diols, J. Chem. Soc. Chem. Commun., 213.
Gibbons, G.F., Mitropoulos, K.A., and Pullinger, C.R. (1976) Lanosterol 14α-Demethylase. The Metabolism of Some Potential Intermediates by Cell-free Systems from Rat Lier. Biochem. Biophys. Res. Commun. 69, 781.
Brown, M.S., Goldstein, J.L., and Dietschy, J.M. (1979) Active and Inactive Forms of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase in the Liver of the Rat. Comparison with the Rate of Cholesterol Synthesis in Different Physiological States. J. Biol. Chem. 254, 5144–5149.
Iglesias, J. and Gibbons, G.F. (1989) Oxidative Metabolism of Cholesterol Precursors, Sensitivity to Ketoconazole, an Inhibitor of Cytochrome P-450, Steroids 53, 311–328.
Pullinger, C.R., and Gibbons, G.F. (1983) The Relationship Between the Rate of Hepatic Sterol Synthesis and the Incorporation of [3H] Water, J. Lipid Res. 24, 1321–1328.
Bellamine, A., Mangla, A.T., Nes, W.D., and Waterman, M.R. (1999) Characterization and Catalytic Properties of the Sterol 14α-Demethylase from Mycobacterium tuberculosis, Proc. Natl. Acad. Sci. USA 96, 8937–8942.
Podust, L.M., Poulos, T.L. and Waterman, M.R. (2001) Crystal Structure of Cytochrome P450 14α-Sterol Demethylase (CYP51) from Mycobacterium tuberculosis in Complex with Azole Inhibitors. Proc. Natl. Acad. Sci. USA 98, 3068–3073.
Byskov, A.G., Andersen, C.Y., Nordholm, L., Thogersen, H., Xia, G., Wassmann, O., Andersen, J.V., Guddal, E., and Roed, T. (1995) Chemical Structure of Sterols That Activate Oocyte Meiosis, Nature 374, 559–562.
Rozman, D., and Waterman, M.R. (1998) Lanosterol 14α-Demethylase (CYP51) and Spermatogenesis, Drug Metab. Dispos. 26, 1199–1201.
Shimano, H. (2001) Sterol Regulatory Element-Binding Proteins (SREBPs): Transcriptional Regulators of Lipid Synthetic Genes. Prog. Lipid Res. 40:439–452.
Brown, A.J., Sun, L., Feramisco, J.D., Brown, M.S., and Goldstein, J.L. (2002) Cholesterol Addition to ER Membranes Alters Conformation of SCAP, the SREBP Escort Protein That Regulates Cholesterol Metabolism, Mol. Cell. 10, 237–245.
Saucier, S.E., Kandutsch, A.A., Phirwa, S., and Spencer, T.A. (1987) Accumulation of Regulatory Oxysterols, 32-Oxolanosterol and 32-Hydroxylanosterol in Mevalonate-Treated Cell Cultures, J. Biol. Chem. 262, 14056–14062.
Tabacik, C., Aliau, S., Astruc, M., and Crastes de Paulet, A. (1981) Post-HMG-CoA Reductase Regulation of Cholesterol Biosynthesis in Normal Human Lymphocytes and Lanosten-3β-ol-32-al, a Natural Inhibitor, Biochem. Biophys. Res. Commun. 101, 1087–1095.
Gibbons, G.F., Pullinger, C.R., and Mitropoulos, K.A. (1979) Studies on the Mechanism of Lanosterol 14α-Demethylase. A Requirement for Two Distinct Types of Mixed Function Oxidase. Biochem. J. 183, 309–315.
Janowski, B.A., Grogan, M.J., Jones, S.A., Wisely, G.B., Kliewer, S.A., Corey, E.J., and Mangelsdorf, D.J. (1999) Structural Requirements of Ligands for the Oxysterol Liver X Receptors LXRα and LXRβ. Proc. Natl. Acad. Sci. U.S.A. 96, 266–271.
Kandutsch, A.A., and Chen, H.W. (1974) Inhibition of Sterol Synthesis in Cultured Mouse Cells by Cholesterol Derivatives Oxygenated in the Side Chain, J. Biol. Chem. 249, 6057–6061.
Kandutsch, A.A., and Chen, H.W. (1978) Inhibition of Cholesterol Synthesis by Oxygenated Sterols. Lipids 13, 704–707.
Martin, K.O., Reiss, A.B., Lathe, R., and Javitt, N.B. (1997) 7α-Hydroxylation of 27-Hydroxycholesterol: Biologic Role in the Regulation of Cholesterol Synthesis, J. Lipid Res. 38, 1053–1058.
Kuipers, F., Havinga, R., Huijsmans, C.M., Vonk, R.J., and Princen, H.M. (1989) Inhibition and Induction of Bile Acid Synthesis by Ketoconazole. Effects on Bile Formation in the Rat, Lipids 24, 759–764.
Kempen, H.J., van Son, K., Cohen, L.H., Griffioen, M., Verboom, H., and Havekes, L. (1987) Effect of Ketoconazole on Cholesterol Synthesis and on HMG-CoA Reductase and LDL-Receptor Activities in Hep G2 cells. Biochem. Pharmacol. 36, 1245–1249.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Gibbons, G.F. The role of cytochrome P450 in the regulation of cholesterol biosynthesis. Lipids 37, 1163–1170 (2002). https://doi.org/10.1007/s11745-002-1016-x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-002-1016-x